New semisynthetic teicoplanin derivatives have comparable in vitro activity to that of oritavancin against clinical isolates of VRE
dc.contributor.author | Szűcs, Zsolt | |
dc.contributor.author | Ostorházi, Eszter | |
dc.contributor.author | Kicsák, Máté | |
dc.contributor.author | Nagy, Lajos | |
dc.contributor.author | Borbás, Anikó | |
dc.contributor.author | Herczegh, Pál | |
dc.date.accessioned | 2019-09-17T19:34:08Z | |
dc.date.available | 2019-09-17T19:34:08Z | |
dc.date.issued | 2019 | |
dc.date.oa | 2019-09-18 | |
dc.date.pasync | 2023-01-18T00:06:23Z | |
dc.date.updated | 2020-07-02T00:30:18Z | |
dc.description.corrector | LB | |
dc.identifier.citation | Journal Of Antibiotics. -72 : 7 (2019), p. 524-534. -J. Antibiot. - 0021-8820 | |
dc.identifier.doi | http://dx.doi.org/10.1038/s41429-019-0164-1 | |
dc.identifier.issn | 0021-8820 | |
dc.identifier.opac | http://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM080877 | |
dc.identifier.uri | http://hdl.handle.net/2437/273572 | |
dc.identifier.url | http://www.nature.com/articles/s41429-019-0164-1 | |
dc.language | eng | |
dc.rights.access | open access post-print | |
dc.rights.embargo | 6 | |
dc.rights.owner | Springer Nature | |
dc.subject.mab | Természettudományok | |
dc.subject.mab | Kémiai tudományok | |
dc.tender | EFOP-3.6.3-VEKOP-16-2017-00009 | |
dc.tender | GINOP-2.3.2-15-2016-00008 | |
dc.title | New semisynthetic teicoplanin derivatives have comparable in vitro activity to that of oritavancin against clinical isolates of VRE | |
dc.type | folyóiratcikk | |
dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Nincs kép
- Név:
- FILE_UP_1_Teicoplanin_VRE_ZsSzucs_2019_revision2.0.pdf
- Méret:
- 544 KB
- Formátum:
- Adobe Portable Document Format
- Leírás:
- post-print